We previously reported that targeting HMGB1 with monoclonal antibodies or BoxA extends the survival of mice xenografted with human MM cells by interfering with tumor cell proliferation (Yang et al,2015). This evidence concerns the gene HMGB1 and Miyoshi myopathy.